Within3 Unveils Major Insights Management Platform Enhancements Capable of Eliminating 90% of the Workload Associated with Insights Moderation, Analysis, and Reporting

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

New AI-driven Moderator Assistant changes how pharmaceutical companies approach insight gathering, engagement, and critical decision-making processes.

Within3 today announced a major step forward in delivering business impact through artificial intelligence (AI) in the drug commercialization arena. The company’s updated Insights Management Platform, built on proven AI capabilities and unique to the market, allows life science companies to rethink how they engage audiences, drive insights, and iterate on business strategies.

Within3 is expanding its industry-leading group engagement applications suite with an AI-powered Moderator Assistant, providing 3-7x more real-time feedback versus typical methods like web conferences or in-person meetings and dramatically reducing the time and effort required to monitor and analyze insights.

“Our goal is to remove 90% of the work and cost from the process of gathering, analyzing, and integrating insights, while at the same time improving insight quality and decision-making,” said Lance Hill, Within3 CEO. “We have a significant lead over any other company in the life science market in understanding insights management, and innovations like this are helping us fundamentally change how our customers can effectively bring new therapies to the patients that need them.”

The new version of the Insights Management Platform also includes a completely redesigned group engagement experience focused on further maximizing physician and patient participation. The new system is based on behavioral data from 70,000+ HCP and patient advisor users and Within3’s 15 years of partnership with the world’s top 20 pharmaceutical companies.

In its first week of availability, 23 pharmaceutical companies have already begun upgrading to the new release, with more expected in the coming weeks.

To schedule a demo of this latest version of Within3’s Insights Management platform, please click here.

ABOUT WITHIN3

Within3 is the world leader in life science insights management. Our insights management platform gathers, integrates, and analyzes insights better than any other platform on the market, reducing insight reporting from months to days and eliminating 90% of the workload. Companies use Within3 to drive strategy-impacting decisions up to 3x faster and ensure the customer's voice is heard across the enterprise. To learn more about the insights management platform or to request a demo, visit www.within3.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.24
-4.63 (-1.71%)
AAPL  354.86
+6.35 (1.82%)
AMD  562.14
+46.93 (9.11%)
BAC  50.68
+0.00 (0.00%)
GOOG  291.93
+7.00 (2.46%)
META  640.40
-0.99 (-0.15%)
MSFT  521.36
-11.80 (-2.21%)
NVDA  176.72
+7.83 (4.64%)
ORCL  129.81
+11.83 (10.02%)
TSLA  393.34
+13.56 (3.57%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.